Literature DB >> 9244266

Cloning and expression in Escherichia coli of genetic determinants for production of and immunity to microcin E492 from Klebsiella pneumoniae.

M Wilkens1, J E Villanueva, J Cofré, J Chnaiderman, R Lagos.   

Abstract

Microcin E492 is a polypeptide antibiotic that is produced and excreted by Klebsiella pneumoniae RYC492. The genetic determinants for microcin synthesis and immunity were cloned in Escherichia coli VCS257 into the cosmid vector pHC79, starting from total DNA of K. pneumoniae RYC492. The microcin E492 expressed in E. coli had the same properties as that of K. pneumoniae, i.e., the same molecular weight, the ability to form ionic channels in planar phospholipid bilayers, and essentially identical biological properties. Microcin E492 expression in E. coli, like that in K. pneumoniae, was mainly in the exponential phase of growth, declining in the stationary phase. The immunity determinant was subcloned into the same vector, and its expression was found to disappear in the stationary phase. This phenomenon is not dependent on rpoS, the stationary-phase sigma factor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9244266      PMCID: PMC179325          DOI: 10.1128/jb.179.15.4789-4794.1997

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  19 in total

Review 1.  Genetics of ribosomally synthesized peptide antibiotics.

Authors:  R Kolter; F Moreno
Journal:  Annu Rev Microbiol       Date:  1992       Impact factor: 15.500

2.  Stationary-phase-inducible "gearbox" promoters: differential effects of katF mutations and role of sigma 70.

Authors:  D E Bohannon; N Connell; J Keener; A Tormo; M Espinosa-Urgel; M M Zambrano; R Kolter
Journal:  J Bacteriol       Date:  1991-07       Impact factor: 3.490

3.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa.

Authors:  H Schägger; G von Jagow
Journal:  Anal Biochem       Date:  1987-11-01       Impact factor: 3.365

4.  Factors affecting microcin E492 production.

Authors:  V de Lorenzo
Journal:  J Antibiot (Tokyo)       Date:  1985-03       Impact factor: 2.649

5.  Microcin E492, a low-molecular-weight peptide antibiotic which causes depolarization of the Escherichia coli cytoplasmic membrane.

Authors:  V de Lorenzo; A P Pugsley
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

6.  Microcin-mediated interactions between Klebsiella pneumoniae and Escherichia coli strains.

Authors:  V de Lorenzo; J L Martínez; C Asensio
Journal:  J Gen Microbiol       Date:  1984-02

7.  Colicin V-treated Escherichia coli does not generate membrane potential.

Authors:  C C Yang; J Konisky
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

8.  Regulation of transcription of katE and katF in Escherichia coli.

Authors:  M R Mulvey; J Switala; A Borys; P C Loewen
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

9.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

10.  Microcin-E492-insensitive mutants of Escherichia coli K12.

Authors:  A P Pugsley; F Moreno; V de Lorenzo
Journal:  J Gen Microbiol       Date:  1986-12
View more
  20 in total

1.  Microcin E492 is an unmodified peptide related in structure to colicin V.

Authors:  Anne-Marie Pons; Nathalie Zorn; David Vignon; François Delalande; Alain Van Dorsselaer; Gilles Cottenceau
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines.

Authors:  Claudio Hetz; María Rosa Bono; Luis Felipe Barros; Rosalba Lagos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

3.  Antibacterial activity evaluation of microcin J25 against diarrheagenic Escherichia coli.

Authors:  S Sable; A M Pons; S Gendron-Gaillard; G Cottenceau
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

4.  Characterization of a novel microcin that kills enterohemorrhagic Escherichia coli O157:H7 and O26.

Authors:  Lauren J Eberhart; James R Deringer; Kelly A Brayton; Ashish A Sawant; Thomas E Besser; Douglas R Call
Journal:  Appl Environ Microbiol       Date:  2012-07-06       Impact factor: 4.792

5.  Cooperative uptake of microcin E492 by receptors FepA, Fiu, and Cir and inhibition by the siderophore enterochelin and its dimeric and trimeric hydrolysis products.

Authors:  Erwin Strahsburger; Marcelo Baeza; Octavio Monasterio; Rosalba Lagos
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

6.  Bactericidal activity of both secreted and nonsecreted microcin E492 requires the mannose permease.

Authors:  Sylvain Bieler; Filo Silva; Claudio Soto; Dominique Belin
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

Review 7.  Genome mining for ribosomally synthesized natural products.

Authors:  Juan E Velásquez; Wilfred A van der Donk
Journal:  Curr Opin Chem Biol       Date:  2010-11-20       Impact factor: 8.822

Review 8.  How nature morphs peptide scaffolds into antibiotics.

Authors:  Elizabeth M Nolan; Christopher T Walsh
Journal:  Chembiochem       Date:  2009-01-05       Impact factor: 3.164

9.  Microcin e492 amyloid formation is retarded by posttranslational modification.

Authors:  Andrés Marcoleta; Macarena Marín; Gabriela Mercado; José María Valpuesta; Octavio Monasterio; Rosalba Lagos
Journal:  J Bacteriol       Date:  2013-07-08       Impact factor: 3.490

10.  Identification and properties of the genes encoding microcin E492 and its immunity protein.

Authors:  R Lagos; J E Villanueva; O Monasterio
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.